Gsk (GLAXF) Profit After Tax (2009 - 2026)

Gsk's Profit After Tax history runs 18 years deep, the most recent figure standing at $2.5 billion for Q1 2026.

• In Q1 2026, Profit After Tax rose 11.09% year-over-year to $2.5 billion; the TTM figure through Mar 2026 stood at $10.0 billion (up 33.55% YoY), while the FY2025 annual figure was $8.3 billion, up 119.82% from the prior year.
• Profit After Tax was $2.5 billion for Q1 2026 at Gsk, up from $967.0 million in the prior quarter.
• In the past five years, Profit After Tax ranged from a high of $4.2 billion in Q4 2023 to a low of $81.9 million in Q3 2024.
• Historically, Profit After Tax has averaged $2.1 billion across 5 years, with a median of $2.2 billion in 2023.
• The sharpest annual moves came in 2024 and 2025: Profit After Tax slumped 95.79% in 2024, then surged 4462.94% in 2025.
• A 5-year view of Profit After Tax shows it stood at $3.0 billion in 2022, then surged by 41.93% to $4.2 billion in 2023, then declined by 26.94% to $3.1 billion in 2024, then sank by 68.41% to $967.0 million in 2025, then soared by 156.38% to $2.5 billion in 2026.
• The last three Profit After Tax figures came in at $2.5 billion (Q1 2026), $967.0 million (Q4 2025), and $3.7 billion (Q3 2025), per Business Quant data.